Pentazocine lactate

This classification denotes an opioid receptor agonist with the molecular formula C19H27NO.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P2XIB510O, chemically known as 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11r*)-, compd. with 2-hydroxypropanoic acid (1:1) but more generally known as pentazocine lactate, which bears US NIH Compound Identifier 66386. European Medicines Agency schedules Pentazocine lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03686MIG. Most nations, for tariff and trade purposes, schedule pentazocine lactate under HS 29333300 and SITC 51574. As of Q4 2014, PENTAZOCINE LACTATE remains US FDA's Preferred Term for this commodity. Pentazocine lactate bears US NLM identifiers UMLS ID C0700554 and NCI Concept Code C76851. SMILES: C[C@H]1[C@H]2CC3CCC(CC3[C@@]1(CCN2CC=C(C)C)C)O.CC(C(=O)O)O.